A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

LA CAB plus RPV effectively maintained virologic suppression among patients with infection in real-world clinical practice.

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

A new study highlights a historic step in personalized medicine, utilizing CRISPR gene-editing technology for a ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Amy Grant joined artists Matt Maher, Brandon Health, Charlie Peacock and Steve Taylor at a performance at Otter Creek Church ...

Newsday Zimbabwe She was speaking in an interview on the sidelines of the ongoing Sadc Joint Meeting of Ministers Responsible for Education in Harare yesterday. THE University of Zimbabwe Clinical ...

The FDA greenlights lenacapavir, a semi-annual injectable that prevents infection in over 96% of cases. From a daily pill for ...

The HIV-Brazil Cohort Study: Design, Methods and Participant Characteristics. PLoS One. 2014;9(5):e95673. 2 Remor E. Valoración de la adhesión al tratamiento antirretroviral en pacientes VIH+.